← Evidence map

ReviewMolecular therapy. Methods & clinical development2021

Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing.

Eric Alves et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

23 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34095343